https://www.selleckchem.com/pr....oducts/disodium-phos
Glycopyrronium tosylate (GT; Qbrexza [glycopyrronium] cloth, 2.4%) is a topical anticholinergic approved (USA) for primary axillary hyperhidrosis in patients aged ≥9years. The objective of this study was to compare the pharmacokinetics and safety of GT to oral glycopyrrolate (phase I study) and assess the relationship between glycopyrronium pharmacokinetics and anticholinergic-related adverse events or efficacy with population pharmacokinetics using data from two phase II studies. In the phase I study, study staff applied GT
Like
Comment
Share
